Vaccine Response clinical trials

Explore recruiting vaccine response clinical trials.

Recruiting vaccine response studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vaccine Response trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Optimisation of lymph node fine needle aspiration to study pneumococcal vaccine-induced immunity

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

(BIPAS) A prospective trial to assess Pneumococcal vaccine B cell response in patients without a spleen: a controlled study.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Prospective Randomized trial of Everolimus replacing MMF/MP Acid by the RECOVAC consortium to increase VACcine response in kidney transplant patients

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Antibiotics, Microbiology and Immunology in Children with Chronic wet Cough - the AMIC study

Norway

Therapeutic use (Phase IV) EU CTIS Study details

Characterization of the immune response in immunosuppressed patients with rheumatic diseases, including to the recombinant zoster vaccine

France

Therapeutic use (Phase IV) EU CTIS Study details

Safety and immunogenicity of Shingrix vaccination in patients suffering from Psoriasis or Psoriatic arthritis

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Vaccine Response trials by city

Vaccine Response in Toronto Vaccine Response in Vancouver Vaccine Response in Montreal Vaccine Response in Calgary Vaccine Response in Edmonton Vaccine Response in Ottawa Vaccine Response in Winnipeg Vaccine Response in Quebec City Vaccine Response in Hamilton Vaccine Response in Kitchener Vaccine Response in London Vaccine Response in Halifax Vaccine Response in New York Vaccine Response in Los Angeles Vaccine Response in Chicago Vaccine Response in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease